SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced that the final 5-year safety and efficacy data for ArteFill®, the Company’s FDA-approved non-resorbable injectable dermal filler will be presented at the national meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) on April 20, 2007 in New York City by Steven R. Cohen, MD, FACS, Clinical Professor, Division of Plastic Surgery, University of California, San Diego, School of Medicine and lead ArteFill clinical investigator. The session will also include a live patient workshop to demonstrate the proper techniques in the treatment of nasolabial folds (smile lines).
